Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

Similar articles for PubMed (Select 21439507)

1.

Consensus statement on the role of fluoroquinolones in the management of urinary tract infections.

Hsueh PR, Lau YJ, Ko WC, Liu CY, Huang CT, Yen MY, Liu YC, Lee WS, Liao CH, Peng MY, Chen CM, Chen YS.

J Microbiol Immunol Infect. 2011 Apr;44(2):79-82. doi: 10.1016/j.jmii.2011.01.015. Epub 2011 Jan 18. No abstract available.

PMID:
21439507
2.

Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli.

Gagliotti C, Buttazzi R, Sforza S, Moro ML; Emilia-Romagna Antibiotic Resistance Study Group.

J Infect. 2008 Sep;57(3):179-84. doi: 10.1016/j.jinf.2008.07.004. Epub 2008 Aug 15.

PMID:
18707763
3.

Effect of lactoferricin on fluoroquinolone susceptibility of uropathogenic Escherichia coli.

Longhi C, Marazzato M, Conte MP, Iebba V, Schippa S, Seganti L, Comanducci A.

J Antibiot (Tokyo). 2009 Feb;62(2):109-11. doi: 10.1038/ja.2008.22. Epub 2009 Jan 23. No abstract available.

PMID:
19198637
4.

Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates.

Caron F, Etienne M.

Am J Med. 2010 Mar;123(3):e13. doi: 10.1016/j.amjmed.2009.08.024. No abstract available.

PMID:
20193811
5.

Emergence of fluoroquinolone resistance in Escherichia coli isolates at the department of clinical hematology.

Zemkova M, Kotlarova J, Merka V, Cermak P, Vlcek J, Jebavy L.

New Microbiol. 2007 Oct;30(4):423-30.

6.

Management of complicated urinary tract infections in the era of antimicrobial resistance.

Bader MS, Hawboldt J, Brooks A.

Postgrad Med. 2010 Nov;122(6):7-15. doi: 10.3810/pgm.2010.11.2217. Review.

PMID:
21084776
8.

Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.

Karlowsky JA, Thornsberry C, Jones ME, Sahm DF.

Clin Infect Dis. 2003 Jan 15;36(2):183-7. Epub 2003 Jan 3.

9.

In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance.

Gualco L, Schito AM, Schito GC, Marchese A.

Int J Antimicrob Agents. 2007 Jun;29(6):679-87. Epub 2007 Mar 23.

PMID:
17363225
10.

[Etiological profile of urinary tract infections and antimicrobial susceptibility of urinary pathogens].

Eiros Bouza JM, Ochoa Sangrador C; Grupo Investigador del Proyecto.

An Pediatr (Barc). 2007 Nov;67(5):461-8. Review. Spanish.

12.

Utilization of fluoroquinolones and Escherichia coli resistance in urinary tract infection: inpatients and outpatients.

Urbánek K, Kolár M, Strojil J, Koukalová D, Cekanová L, Hejnar P.

Pharmacoepidemiol Drug Saf. 2005 Oct;14(10):741-5.

PMID:
15880441
13.

Impact of low-level resistance to fluoroquinolones due to qnrA1 and qnrS1 genes or a gyrA mutation on ciprofloxacin bactericidal activity in a murine model of Escherichia coli urinary tract infection.

Allou N, Cambau E, Massias L, Chau F, Fantin B.

Antimicrob Agents Chemother. 2009 Oct;53(10):4292-7. doi: 10.1128/AAC.01664-08. Epub 2009 Jul 27.

14.

Co-trimoxazole and quinolone resistance in Escherichia coli isolated from urinary tract infections over the last 10 years.

Karaca Y, Coplu N, Gozalan A, Oncul O, Citil BE, Esen B.

Int J Antimicrob Agents. 2005 Jul;26(1):75-7.

PMID:
15955672
15.

[Urinary tract infection and fluoroquinolone resistance].

Luisoni A, Cometta A.

Rev Med Suisse Romande. 2003 Mar;123(3):155-7. French.

PMID:
15095700
16.

Clinical implications. In vitro resistance of E coli to TMP/SMX.

[No authors listed]

Postgrad Med. 2001 Aug;110(2 Suppl):11-5; discussion 26-7. doi: 10.3810/pgm.08.2001.suppl15.82. No abstract available.

PMID:
19667571
17.

[Uncomplicated urinary tract infections, what about fosfomycin and nitrofurantoin in 2006?].

Honderlick P, Cahen P, Gravisse J, Vignon D.

Pathol Biol (Paris). 2006 Oct-Nov;54(8-9):462-6. Epub 2006 Oct 5. French.

PMID:
17027182
18.

[Using antibiotics in urinary tract infection in a first level of attention health care unit in Bogotá, Colombia].

Murillo-Rojas OA, Leal-Castro AL, Eslava-Schmalbach JH.

Rev Salud Publica (Bogota). 2006 May-Aug;8(2):170-81. Spanish.

19.

Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates.

Johnson L, Sabel A, Burman WJ, Everhart RM, Rome M, MacKenzie TD, Rozwadowski J, Mehler PS, Price CS.

Am J Med. 2008 Oct;121(10):876-84. doi: 10.1016/j.amjmed.2008.04.039.

PMID:
18823859
20.

Risk factors for urinary tract infections due to ciprofloxacin-resistant Escherichia coli in a tertiary care urology department in Switzerland.

Nicoletti J, Kuster SP, Sulser T, Zbinden R, Ruef C, Ledergerber B, Weber R.

Swiss Med Wkly. 2010 Jul 15;140:w13059. doi: 10.4414/smw.2010.13059.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk